This first report showed that edible plant-derived nanovesicles with a cell growth inhibitory effect on CRC cells depend on p53 activation status via the macropinocytosis pathway, and that p53 inactivation induced macropinocytosis activity. The gene discussed is TP53; the disease is colorectal carcinoma.